WallStSmart
SLS

Sellas Life Sciences Group Inc

NASDAQ: SLS · HEALTHCARE · BIOTECHNOLOGY

$4.95
+6.00% today

Updated 2026-04-30

Market cap
$900.52M
P/E ratio
P/S ratio
26.90x
EPS (TTM)
$-0.25
Dividend yield
52W range
$1 – $6
Volume
6.7M

Sellas Life Sciences Group Inc (SLS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+33.2%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+37.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+6.6%
2026-03-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-13$-0.05+28.6%$5.03$5.36+6.6%
2025-11-12$-0.06+25.0%$1.51$1.46-3.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.07$-0.05+28.6%
2025-09-30$-0.08$-0.06+25.0%
2025-06-30$-0.08$-0.07+12.5%
2025-03-31$-0.21$-0.07+66.7%
2024-12-31$-0.11$-0.08+25.0%
2024-09-30$-0.13$-0.10+21.1%
2024-06-30$-0.16$-0.13+18.8%
2024-03-31$-0.16$-0.21-31.2%
2023-12-31$0.09$-0.25-377.8%
2023-09-30$0.03$-0.33-1200.0%
2023-06-30$-0.35$-0.31+11.4%
2023-03-31$-0.29$-0.47-62.1%

Frequently asked questions

Has Sellas Life Sciences Group Inc beaten earnings estimates?
Sellas Life Sciences Group Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +33.2% over the last 4 quarters.
How does SLS stock react to earnings?
SLS stock has moved an average of +1.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.